Latest
Immune Thrombocytopenia: Durable Responses Noted With Eltrombopag Plus Pulsed Dexamethasone
Mass Spectrometry for Detection of Monoclonal Gammopathy of Undetermined Significance
Inhibitor Incidence in Severe Hemophilia B
Splenomegaly May Be a Negative Prognostic Factor in Essential Thrombocythemia and Polycythemia Vera
Female Patients With Bleeding Disorders Included in the American Thrombosis and Hemostasis Network Dataset
Rivaroxaban for Children With Acute Venous Thromboembolism
Facts About Leukemia: 6 Myths You Might Encounter at Your Practice
Time of Day for Taking Warfarin Does Not Matter
Low-Dose Aspirin in Children With Kawasaki Disease
Why Do Patients With Myelofibrosis Discontinue Ruxolitinib?
Dasatinib Tops Imatinib for Ph+ Acute Lymphoblastic Leukemia
Peripherally Inserted Central Catheters May Increase Venous Thromboembolism Risk in Children
Featured Content
Considering Personalized Neoantigen Vaccine Approaches for Multiple Myeloma
Neoantigens may have the ability to provoke the immune system into recognizing and killing cancer cells in patients with multiple myeloma.
CAR-T Therapy: Supporting Evidence and Value Considerations
Although CAR-T therapies have shown favorable response rates, they can be incredibly costly and may not be priced in alignment with their benefits.
Diagnosis and Management of Thrombocytopenia in Pregnancy
Researchers reviewed the diagnosis and management of several pregnancy-specific causes of thrombocytopenia.
Some Targeted Therapies May Miss the Mark
Ten different drugs continued to kill cancer cells even when their target proteins were removed.
Expert Q&A: The Current State of Gene Therapy for Hemophilia
Although gene therapy shows promise in curing hemophilia, questions about its efficacy, optimal administration, and outcomes remain.
